Bank of England CCP Resolution Paper, Malta Tokenisation Consultation, ASIC Sustainability Reporting & EU AI Act High-Risk Guidelines — Global Regulatory Briefing May 24, 2026
Welcome to Carver's regulatory updates podcast for the week of May 24, 2026.
The European Commission has issued draft guidelines to assist artificial intelligence providers and deployers in assessing whether their AI systems qualify as high-risk under the AI Act. Stakeholders are invited to provide feedback on these draft guidelines by June 23, 2026.
In the European Union and European Economic Area, new clinical trial targets established in 2025 are being tracked. The goals include authorising an additional 500 multinational clinical trials by 2030 and achieving 66 percent of clinical trials recruiting participants within 200 days by the same year. The FAST-EU initiative supports accelerated clinical trial authorisation processes. Organisations interested in participating in the FAST-EU pilot must submit an Expression of Interest prior to clinical trial applications.
Turning to Spain, El Ministerio para la Transición Ecológica y el Reto Demográfico, or El MITECO, has proposed a third modification to the 2021-2026 electricity transmission network plan. This modification includes the installation of four e-STATCOM compensators integrated into the network, the addition of 28 reactances, and the renewal of four others to improve voltage control.
In the United Kingdom, the Bank of England has published a discussion paper outlining its current thinking on central counterparty resolution execution and resolvability outcomes. The paper covers resolution powers, creditor hierarchy, returning value to creditors, and statutory partial tear-up powers. Central counterparties, or CCPs, must have capabilities to deploy recovery and resolution tools on the Bank’s instruction, secure continuity of critical clearing services through resolution, and provide timely data, modelling, and analysis to the Bank, Her Majesty’s Treasury, and independent valuers.
Malta’s Financial Services Authority has launched a public consultation on the tokenisation of financial instruments and real-world assets. The consultation explores integrating distributed ledger technology within Malta’s financial services framework, assessing market readiness, legal and regulatory considerations, and infrastructure needs such as token registries and interoperability. Stakeholders are encouraged to provide feedback on market appetite, strategic positioning, and identify any legal or regulatory gaps.
In Australia, the Australian Securities and Investments Commission, or ASIC, has set financial reporting, audit, and sustainability focus areas for the fiscal year 2026 to 2027. ASIC will review financial reports and audits of listed and unlisted companies, registered superannuation entities, and managed investment schemes. New focus areas include disclosures related to decommissioning and site-restoration costs, as well as monitoring audit firms’ remedial actions. Sustainability reporting oversight will continue with updated guidance and relief. ASIC plans to review 25 audit files selected based on risk indicators and random selection, focusing on significant judgements such as revenue recognition and asset impairment.
In the United States, specifically California, the Commissioner of Financial Protection and Innovation has issued an order waiving the mortgage insurance requirement under California Code of Regulations, title 10, section 30.802(a)(1)(B) for state-chartered credit unions. Additionally, detailed procedures and sample forms for merger approvals under Financial Code sections 15200 and following have been provided.
Bolton Medical in the United States has issued a voluntary field safety notice concerning the RelayPro Thoracic Stent Graft System. The notice addresses RelayPro N4 Non-Bare Stent devices of 32 millimeters or greater, due to cases of failure to release the partially deployed endoprosthesis from the delivery system, including fatal outcomes. Manufacturing modifications have been implemented to reduce failure risk, and investigations are ongoing. Users are advised to consider alternative endoprosthesis options before using affected devices and to follow additional instructions for managing failure to release the endoprosthesis.
Surgical Specialties Mexico S. DE R.L. DE C.V. has issued an urgent field safety notice for the Sharpoint 2.2 millimeter angled, double-bevel microsurgical knives. A batch of these 2.2 millimeter knives was mistakenly replaced with 3.0 millimeter knives, posing a risk of wider incisions requiring sutures in eye surgery. Medical professionals are instructed to identify and quarantine the affected product batch FA22CHQ, return the products to the manufacturer, and communicate the safety notice to relevant users and organisations.
Finally, in Greece, the latest annual reports detail market conditions, macroeconomic factors, regulatory enforcement actions including fines and approvals, and ongoing reforms in the Greek capital market. Listed companies are required to comply with the new corporate governance regime and adhere to sustainable finance and environmental, social, and governance criteria integration in capital market regulation. Obligations under new legislation and supervisory frameworks must also be fulfilled.
That wraps up today's regulatory updates. Visit carveragents.ai for more information.
